Samsung Life Skips Final Bid for KDB Life, Leaving Hanwha, Heungkuk and Korea Investment in Three-Way Race

Hanwha Life, Heungkuk Life and Korea Investment Financial Holding submitted final bids for KDB Life Insurance on August 7, while Samsung Life Insurance, widely regarded as the favorite to win the company, chose not to take part. The surprise absence of Samsung Life reshaped what many in the industry had expected to be a two-horse race into an unpredictable three-way contest.

Samil PwC, the accounting firm managing the sale on behalf of state-run Korea Development Bank, closed the final bidding at 3 p.m. that day. Of the five bidders that had entered the preliminary round, Kyobo Life and Samsung Life dropped out before the deadline, while Heungkuk Life, Hanwha Life and Korea Investment Financial Holding moved forward to the decisive stage.

Samsung Life had set up a dedicated task force and actively examined the acquisition, fueling expectations that it would emerge as a top contender alongside Heungkuk Life. But after completing due diligence, the insurer ultimately decided against submitting a final offer. Industry sources said the decision reflected a broad assessment of the likely purchase price, the capital burden tied to KDB Life's balance sheet, and the limited business upside the deal would bring given Samsung Life's position as the market leader.

By contrast, Heungkuk Life, which needs external growth to expand its business, has been the most consistently aggressive suitor throughout the process. Korea Investment Financial Holding is looking to add an insurance unit to diversify its portfolio. Hanwha Life's participation drew particular attention because the company had recently been named preferred bidder for Aju Capital in a deal worth over 1 trillion won, leading many to assume it would sit out the KDB Life bidding.

The sale of KDB Life has been underway since 2014, and this marks the seventh attempt to find a buyer in twelve years. Previous efforts collapsed repeatedly — in 2020, JC Partners was picked as preferred bidder but failed to win regulatory approval for a change in major shareholder, and in 2023 Hana Financial Group walked away after being named preferred bidder, citing the added capital requirements the acquisition would entail.

KDB Life carried out a 500 billion won rights offering last year to shore up its capital position, though analysts note further capital top-ups will likely be needed regardless of who ultimately buys the insurer. Samil PwC is expected to evaluate the three remaining bidders on price, funding capacity and post-acquisition management plans before naming a preferred bidder. Given that past sales have unraveled even after a preferred bidder was chosen, uncertainty is likely to persist until a final contract is signed, with the eventual outcome hinging largely on how much of the price and capital burden the winning bidder is willing to absorb.